Shares of Solana Company (NASDAQ: HSDT) jumped approximately 17% on Friday, February 13, 2026, following the announcement of a new financial structure that allows institutions to borrow against their natively staked SOL tokens while keeping the assets in custody. The product, developed in partnership with Anchorage Digital and the Solana lending protocol Kamino, is designed to unlock liquidity from corporate treasury holdings without requiring token holders to unstake or sell their SOL.
The Nasdaq-listed firm, which rebranded from Helius Medical Technologies in September 2025, saw its stock price rebound to around $2.30 from an all-time low near $1.80 earlier in the week. Despite this surge, the stock remains down roughly 90% since the company pivoted to a Solana-focused treasury strategy last year. The downturn is largely attributed to the sharp decline in SOL's price, which fell from about $245 in September 2025 to around $70 last week before recovering to the mid-$80 range.
Solana Company is currently the second-largest publicly traded holder of SOL, with approximately 2.3 million tokens on its balance sheet worth nearly $200 million. The new borrowing solution aims to provide stability by allowing these treasury holdings to continue earning staking rewards while simultaneously serving as collateral for on-chain loans. "This new financial tool will enable institutional holders of SOL to unlock liquidity while still benefiting from the rewards of staking their tokens," a company spokesperson stated.
The launch reflects a broader trend among publicly listed Solana treasury companies to rely more heavily on staking income and alternative yield strategies amid prolonged market pressure. For instance, Sharps Technology has disclosed its treasury earns roughly a 7% annualized staking yield, while SOL Strategies recently launched a liquid staking token backed by over 500,000 SOL. Upexi has also reported that staking income now constitutes the majority of its company revenue.
